Risk and Health & Life Sciences
Using our proprietary risk analysis frameworks and modeling platforms, Oliver Wyman helps develop sophisticated risk management and capital allocation strategies for our clients in the healthcare and life sciences value chain.
In both the for-profit and not-for-profit sectors, health care providers are facing a rapidly changing operating and risk environment. Their challenges are driven by the care and coverage of the uninsured, new technologies, rising consumerism, pay-for-performance and greater reporting transparency.
As a result of international growth, regulatory requirements, supply chain management, and pipeline development, the Life Sciences industry, including pharmaceutical and biotechnology companies, is operating in an increasingly complex risk environment.
Our firm’s work with healthcare providers and life sciences corporations focuses on design and implementation of ERM frameworks. These frameworks allow clients to better understand their evolving risk profile and to develop risk management approaches that respond to strategic and operational challenges that are not otherwise addressed by “traditional” risk management approaches.
- Post-Crisis Risk Management: Welcoming Cassandra to the Boardroom
- Taking ERM to the Next Stage
- What’s Your Risk Appetite?